Brief Title
Epidemiology and Long-term Outcome of Patients With VHD
Official Title
Epidemiology and Long-term Prognosis of Patients With Valvular Heart Diseases (BIA-WAD Study)
Brief Summary
Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. The aim of the study is analysis the epidemiology and the long-term prognosis among patients with VHD.
Detailed Description
Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. Patients with moderate and severe valvular heart diseases are included into the study. The set of variables subject to interpretation consisted of demographic data, medical history, result of coronary angiography, and type of applied percutaneous and surgical treatment
Study Type
Observational
Primary Outcome
Death
Secondary Outcome
MACCE
Condition
Valvular Disease
Intervention
Innovative medical technologies in invasive cardiology and cardiac surgery
Study Arms / Comparison Groups
VHD patients
Description: Patients with moderate and severe valvular heart diseases
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
2500
Start Date
January 2006
Completion Date
January 2025
Primary Completion Date
January 2010
Eligibility Criteria
Inclusion Criteria: - Valvular heart disease in moderate and severe stages Exclusion Criteria: - Age < 18 years old
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
, ,
Location Countries
Poland
Location Countries
Poland
Administrative Informations
NCT ID
NCT04527367
Organization ID
UMB-KKI-101
Responsible Party
Principal Investigator
Study Sponsor
Medical University of Bialystok
Study Sponsor
, ,
Verification Date
September 2020